(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a session on non-beta emitter PSMA radioligand therapy. Dr.

Direct characterisation analytical techniques do not work, as the actinium is not a normal trace element impurity. The team developed an in-house capability to use actinium 225a as a tracer, which ...

We are a global leader in isotope research, development, and production, meeting the nation's emerging needs for stable and radioactive isotopes. Whether it's national security, industrial, medical or ...

Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...

Read about Actinium Pharmaceuticals Inc (ATNM:XASE) stock and today's latest news and financial updates.

Check out our ATNM stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

A new method uses helium droplets combined with ultrashort laser pulses to trigger chemical reactions in a controlled way.

Using lead-212 as an isotope means that Sanofi and Orano Med can sidestep some of the supply issues that are affecting other RLT producers developing other alpha emitters like actinium-225.

Novartis has struck another deal to strengthen its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology.